OSE Immunotherapeutics To Present Positive Results of Tedopi® Phase 3 Clinical Trial in apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
OSE Immunotherapeutics Presented Positive Final Results of Tedopi® Phase 3 Clinical Trial in apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ A new drug reduced tumor size in patients who have lung cancer patients with a specific, disease-causing change in the gene KRAS, a study found..